ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
701 | 71.745 | 1 | female | 0 | 5 | 328 | CHF | COPD/CHF/Cirrhosis | 3 | 16 | $11-$25k | 0 | 9,478 | 5,019.3398 | null | 14 | white | 23.898438 | 38 | 0.78894 | 0.660889 | 1 | 1 | 0 | no | 0.95 | 0.8 | dnr after sadm | 1 | 53 | 11.5 | 82 | 20 | 36.39844 | null | null | null | 2.099609 | 139 | null | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.544922 |
702 | 65.93298 | 1 | female | 0 | 4 | 715 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | under $11k | 0 | 10,227 | 5,117.5234 | null | 10 | asian | 20.796875 | 30 | 0.810913 | 0.69397 | 8 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 4 | 103 | 8.699219 | 134 | 24 | 36 | 260.8125 | null | null | 1 | 141 | 7.459961 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 |
703 | 69.98199 | 1 | female | 0 | 15 | 680 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 100 | 65,732 | 33,516.375 | null | 34 | black | 28 | 43 | 0.217987 | 0.069992 | 3 | 0 | 0 | no | 0.06 | 0.000216 | no dnr | 15 | 63 | 11.199219 | 110 | 26 | 36.5 | 241.65625 | 3.299805 | 2.699707 | 1.5 | 130 | 7.389648 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
704 | 82.14099 | 1 | male | 0 | 20 | 65 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 26 | 113,460 | 56,403.9375 | null | 15 | black | 23 | 32 | 0.402954 | 0.283997 | 12 | 0 | 0 | metastatic | 0.8 | 0.5 | dnr after sadm | 12 | 75 | 9.199219 | 70 | 22 | 36.5 | 107.14062 | 3.599609 | 0.299988 | 1.299805 | 133 | 7.5 | null | null | null | null | null | null | 4.479492 |
705 | 41.06198 | 0 | female | 0 | 4 | 1,419 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 15 | $11-$25k | 0 | 16,536 | 8,055.3008 | null | 6 | black | 18.898438 | 9 | 0.914917 | 0.883911 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 4 | 117 | 16.898438 | 74 | 24 | 37 | 218.34375 | null | null | 1 | 130 | 7.379883 | null | null | null | null | null | null | 2.039551 |
706 | 56.34998 | 1 | female | 0 | 3 | 1,344 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 4,944 | 2,253.7129 | null | 6 | white | 20.597656 | 12 | 0.892944 | 0.820923 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 87 | 6.699219 | 100 | 24 | 37 | 266.625 | null | null | 0.599976 | 130 | 7.439453 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
707 | 67.72894 | 1 | male | 0 | 9 | 1,325 | CHF | COPD/CHF/Cirrhosis | 3 | 18 | $11-$25k | 0 | 32,258 | 16,843.2656 | null | 10 | white | 15.298828 | 20 | 0.897949 | 0.828979 | 1 | 0 | 0 | no | 0.96 | 0.92 | no dnr | 9 | 110 | 7.599609 | 65 | 24 | 36.5 | null | null | 0.799927 | 1.299805 | 137 | null | null | null | null | null | null | null | 2.985352 |
708 | 51.18698 | 1 | male | 0 | 10 | 1,243 | Colon Cancer | Cancer | 3 | null | null | 0 | 30,006 | 15,566.1562 | null | 11.5 | white | 23.097656 | 39 | 0.75293 | 0.493958 | 1 | 1 | 0 | metastatic | 0.1 | 0.001 | no dnr | 10 | 120 | 11.398438 | 140 | 20 | 39.5 | null | null | 0.299988 | 1.699951 | 135 | null | null | null | null | null | null | null | 3.51709 |
709 | 48.43799 | 1 | male | 1 | 11 | 11 | MOSF w/Malig | ARF/MOSF | 1 | 15 | >$50k | 0 | 275,297 | 131,152.125 | null | 38.5 | white | 49.5 | 93 | 0.023998 | 0.006 | 27 | 0 | 0 | yes | null | null | dnr after sadm | 9 | 58 | 0.599976 | 170 | 26 | 39.89844 | 56 | 2.599609 | 0.599976 | 3.599609 | 150 | 7.329102 | null | null | null | null | null | <2 mo. follow-up | 2.244629 |
710 | 63.573 | 1 | female | 1 | 32 | 32 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $25-$50k | 26 | 231,839 | 99,332.375 | null | 30.75 | white | 34.898438 | 34 | 0.128998 | 0.058998 | 7 | 0 | 0 | metastatic | 0.75 | 0.2 | dnr after sadm | 18 | 60 | 4.099609 | 130 | 23 | 38.69531 | 107.6875 | 2 | 0.599976 | 0.899902 | 125 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 3.240234 |
711 | 56.74197 | 1 | male | 0 | 12 | 738 | Colon Cancer | Cancer | 1 | 18 | $11-$25k | 0 | 41,129 | 20,834.9062 | null | 12.5 | white | 5.199219 | 11 | 0.931885 | 0.839966 | 1 | 0 | 0 | metastatic | 0.95 | 0.85 | no dnr | 12 | 98 | 10.599609 | 82 | 20 | 36.39844 | null | 4.399414 | 0.699951 | 1.099854 | 136 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
712 | 52.43799 | 0 | male | 0 | 17 | 1,411 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 73,122 | 36,176.8438 | null | 22.333328 | white | 19.296875 | 19 | 0.890991 | 0.816895 | 2 | 1 | 0 | no | 0.85 | 0.8 | no dnr | 17 | 67 | 6.299805 | 110 | 22 | 36.39844 | 457.125 | null | null | 0.899902 | 134 | 7.489258 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
713 | 73.59094 | 1 | female | 0 | 124 | 200 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 37 | null | 352,231.25 | null | 34.25 | white | 30.398438 | 49 | 0.379944 | 0.261963 | 11 | 0 | 0 | no | null | null | no dnr | 124 | 68 | 27.5 | 110 | 12 | 38.5 | 90.90625 | 2.399902 | 2.399902 | 1.099854 | 131 | 7.419922 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.776367 |
714 | 56.50098 | 1 | male | 1 | 7 | 7 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | null | 41 | 95,243 | 48,038.875 | null | 26.5 | white | 32.796875 | 54 | 0.22699 | 0.074997 | 15 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 7 | 123 | 16.898438 | 115 | 9 | 37 | 273.3125 | 3.599609 | 11.398438 | 5.899414 | 137 | 7.439453 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
715 | 45.22699 | 0 | male | 0 | 29 | 1,406 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 37 | 213,989 | 110,645.438 | null | 27.5 | white | 23.398438 | 21 | 0.754883 | 0.67688 | 4 | 0 | 0 | no | null | null | no dnr | 29 | 122 | 18.5 | 120 | 6 | 37.29688 | 504 | null | null | 0.699951 | 132 | 7.489258 | null | null | null | null | null | null | 3.437012 |
716 | 54.44498 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 18 | >$50k | 41 | 61,442 | 28,589.9844 | null | 42 | white | 58.695313 | 81 | 0.003 | 0 | 2 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 5 | 30 | 6.799805 | 145 | 20 | 39.19531 | 81 | 2.199707 | 12.699219 | 0.599976 | 131 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 2.519531 |
717 | 85.36096 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | null | 100 | 51,486 | 24,927.7031 | null | 33 | white | 44.296875 | 76 | 0 | 0 | 9 | 0 | 0 | no | 0.01 | 0.000001 | no dnr | 3 | 40 | 18.097656 | 30 | 25 | 38 | 294 | null | 2.5 | 2.699707 | 131 | 7.229492 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
718 | 46.08099 | 0 | male | 0 | 31 | 1,405 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | under $11k | 0 | 170,570 | 84,744.75 | null | 17 | hispanic | 15.099609 | 12 | 0.93689 | 0.891968 | 1 | 0 | 0 | no | null | null | no dnr | 31 | 67 | null | 50 | 16 | 37.79688 | null | null | 0.199982 | 0.899902 | 138 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
719 | 32.42697 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | under $11k | 100 | 382,471 | 201,105.75 | null | 45.5 | white | 43.09375 | 98 | 0.045998 | 0.014 | 13 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 9 | 57 | 39.796875 | 120 | 36 | 35.09375 | 205.6875 | 1.799805 | 16.898438 | 2.199707 | 134 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 4.032227 |
720 | 66.27496 | 1 | male | 0 | 8 | 879 | Colon Cancer | Cancer | 1 | 20 | >$50k | 0 | 18,606 | 9,488.0312 | null | 9 | white | 18.597656 | 11 | 0.791992 | 0.56189 | 1 | 0 | 0 | metastatic | null | null | no dnr | 8 | 83 | 13.398438 | 68 | 20 | 38 | null | 3.199707 | 1.399902 | 1.099854 | 135 | null | null | null | null | 0 | null | null | 0.4948 |
721 | 78.53796 | 1 | female | 0 | 6 | 146 | COPD | COPD/CHF/Cirrhosis | 2 | 16 | $25-$50k | 0 | 8,697 | 5,066.1602 | null | 7 | white | 21.097656 | 28 | 0.775879 | 0.641968 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 6 | 96 | 12.199219 | 96 | 22 | 36 | 157.125 | 3.699707 | 0.599976 | 1.199951 | 142 | 7.399414 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
722 | 50.95099 | 1 | female | 1 | 43 | 43 | MOSF w/Malig | ARF/MOSF | 1 | 12 | null | 26 | 449,923 | 199,117.25 | null | 41.75 | black | 27.296875 | 47 | 0.530884 | 0.415955 | 1 | 0 | 0 | yes | null | null | no dnr | 43 | 63 | 19.398438 | 125 | 14 | 39.39844 | 234 | 2.899902 | 1.399902 | 6.599609 | 144 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
723 | 39.81897 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 13 | null | 100 | 54,871 | 26,152.2031 | null | 40 | white | 60.5 | 102 | 0 | 0 | 3 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 5 | 35 | 18.398438 | 130 | 15 | 38.79688 | 100 | 2.099609 | 20.296875 | 3 | 132 | 7.30957 | null | null | null | null | null | <2 mo. follow-up | 3.381348 |
724 | 31.34299 | 1 | female | 1 | 11 | 11 | Coma | Coma | 1 | null | null | 100 | 148,727 | 66,520.625 | null | 28 | white | 47.59375 | 62 | 0 | 0 | 32 | 0 | 0 | metastatic | null | null | no dnr | 11 | 42 | 20.199219 | 140 | 20 | 38.5 | 68 | null | null | 2.299805 | 132 | 7.339844 | null | null | null | null | null | <2 mo. follow-up | 3.606934 |
725 | 73.14697 | 1 | male | 0 | 11 | 971 | CHF | COPD/CHF/Cirrhosis | 2 | 4 | >$50k | 0 | 20,810 | 13,290.375 | null | 9.5 | white | 21 | 39 | 0.823975 | 0.712891 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 70 | 8.599609 | 65 | 28 | 36 | null | null | null | 2 | 138 | null | null | null | null | null | 4 | no(M2 and SIP pres) | 4 |
726 | 73.70294 | 1 | male | 0 | 7 | 166 | CHF | COPD/CHF/Cirrhosis | 1 | 24 | null | 0 | 14,284 | 8,644.1797 | null | 8 | white | 20.296875 | 45 | 0.830933 | 0.723999 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 77 | 5.299805 | 92 | 28 | 38.09375 | 261.875 | null | 2.299805 | 2.199707 | 137 | 7.479492 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
727 | 71.75397 | 0 | female | 0 | 25 | 1,400 | COPD | COPD/CHF/Cirrhosis | 1 | 9 | under $11k | 26 | 135,615 | 60,638.9062 | null | 22.5 | black | 18.097656 | 15 | 0.794922 | 0.670898 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 25 | 60 | 15.398438 | 110 | 10 | 38.19531 | 300 | 2.799805 | null | 0.899902 | 137 | 7.439453 | null | null | null | null | null | no(M2 and SIP pres) | 2.896973 |
728 | 63.59799 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 44 | 51,942 | 23,758.9062 | null | 39 | white | 69.390625 | 100 | 0 | 0 | 1 | 0 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 2 | 30 | 50.59375 | 115 | 25 | 38.39844 | 56 | 2.5 | 22.796875 | 5.199219 | 129 | 7.579102 | null | null | null | null | null | <2 mo. follow-up | 2.206543 |
729 | 72.323 | 1 | male | 0 | 18 | 66 | Colon Cancer | Cancer | 2 | null | null | 0 | 36,244 | 20,509.875 | null | 11.333328 | white | 28.597656 | 19 | 0.569946 | 0.247986 | 1 | 1 | 0 | metastatic | 0.6 | 0.2 | dnr after sadm | 9 | 81 | 16.296875 | 112 | 20 | 39.19531 | null | 3.099609 | null | 0.799927 | 128 | null | null | null | null | null | null | null | 3.349121 |
730 | 44.12299 | 1 | female | 0 | 28 | 55 | MOSF w/Malig | ARF/MOSF | 2 | 12 | null | 41 | 293,158 | 148,681.25 | null | 19.25 | white | 37.59375 | 71 | 0.084 | 0.031998 | 23 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 28 | 63 | 3.399902 | 160 | 21 | 39.19531 | 348 | null | 9 | 4.899414 | 135 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
731 | 21.74899 | 0 | male | 0 | 23 | 1,396 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | under $11k | 0 | 156,314 | 88,603.3125 | null | 26.333328 | white | 19.898438 | 11 | 0.92395 | 0.896973 | 4 | 0 | 0 | no | null | null | no dnr | 23 | 70 | 10.798828 | 105 | 20 | 38.59375 | 206.09375 | null | null | 0.799927 | 145 | 7.30957 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
732 | 67.85797 | 1 | female | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | >$50k | 0 | 234,034 | 109,152.25 | null | 37.666657 | white | 21.898438 | 34 | 0.771973 | 0.697998 | 13 | 0 | 0 | no | 0.8 | 0.75 | dnr after sadm | 17 | 75 | 6.599609 | 105 | 28 | 36.5 | 183.3125 | 2.099609 | null | 1 | 144 | 7.489258 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
733 | 58.05099 | 0 | female | 0 | 6 | 1,395 | Lung Cancer | Cancer | 2 | 12 | null | 0 | 9,864 | 5,061.0352 | null | 9 | black | 16.5 | 12 | 0.733887 | 0.464966 | 1 | 0 | 0 | metastatic | 0.9 | 0.75 | no dnr | 6 | 79 | 10.298828 | 100 | 24 | 37.39844 | null | null | null | 0.899902 | 137 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.530273 |
734 | 57.84799 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 1 | 14 | $25-$50k | 55 | 139,623 | 68,361.5 | null | 58 | white | 57.796875 | 104 | 0 | 0 | 18 | 0 | 0 | yes | 0.07 | 0.000343 | no dnr | 4 | 48 | 0.049995 | 200 | 32 | 39.29688 | 75.54688 | null | 8.699219 | 1.799805 | 152 | 7.289062 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
735 | 72.56097 | 1 | male | 1 | 28 | 28 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | $25-$50k | 9 | 301,990 | 138,869.5 | null | 26.5 | white | 38.898438 | 57 | 0.181 | 0.093994 | 21 | 0 | 0 | yes | 0.5 | 0.125 | dnr after sadm | 22 | 70 | 15.798828 | 110 | 22 | 36.09375 | 190 | 3.299805 | 26.296875 | 2.399902 | 135 | 7.469727 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
736 | 49.53 | 0 | female | 0 | 4 | 1,392 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 10,545 | 5,904.1562 | null | 10 | black | 15.699219 | 21 | 0.927979 | 0.878906 | 1 | 1 | 0 | no | 1 | 0.95 | no dnr | 4 | 103 | 6.199219 | 86 | 24 | 36.89844 | null | null | null | 1.399902 | 134 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.237305 |
737 | 60.65399 | 1 | male | 1 | 51 | 51 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 26 | 475,387 | 216,298.25 | null | 35.75 | white | 30.5 | 52 | 0.615967 | 0.510986 | 1 | 1 | 0 | no | null | null | dnr after sadm | 44 | 63 | 5.199219 | 125 | 8 | 38.89844 | 114 | 2.399902 | 1.5 | 1.799805 | 137 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 3.022461 |
738 | 69.41797 | 1 | male | 1 | 4 | 4 | Lung Cancer | Cancer | 1 | 14 | $11-$25k | 0 | 7,194 | 3,058.4688 | null | 12 | asian | 26.898438 | 33 | 0.445984 | 0.134979 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 2 | 73 | null | 62 | 34 | 39.19531 | 128.5625 | 3.099609 | 0.299988 | 1.099854 | 133 | 7.479492 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
739 | 25.89699 | 0 | male | 0 | 28 | 1,391 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 251,227 | 126,467.875 | null | 22.5 | hispanic | 33 | 36 | 0.691895 | 0.600952 | 16 | 0 | 0 | yes | 0.75 | 0.7 | no dnr | 28 | 153 | 7.099609 | 110 | 24 | 35.89844 | 76 | 2.799805 | 0.799927 | 2.199707 | 136 | 7.389648 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
740 | 47.43298 | 1 | male | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | $11-$25k | 26 | 169,364 | 82,586.5 | null | 37 | white | 33.796875 | 63 | 0.612915 | 0.507935 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 6 | 73 | 5.099609 | 115 | 24 | 36.89844 | 191.65625 | 2.199707 | 19.296875 | 1.699951 | 141 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 3.063965 |
741 | 36.29797 | 0 | male | 0 | 15 | 1,385 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 48,925 | 26,166.5 | null | 10 | white | 23.597656 | 18 | 0.845947 | 0.746948 | 2 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 15 | 97 | 13.5 | 118 | 16 | 38 | 190 | null | 3.199707 | 0.799927 | 140 | 7.389648 | null | null | null | 0 | null | null | 0.4948 |
742 | 63.07999 | 0 | male | 0 | 9 | 1,384 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | under $11k | 0 | 29,706 | 14,753.0078 | null | 13.5 | hispanic | 31 | 44 | 0.705933 | 0.544922 | 1 | 1 | 0 | no | null | null | no dnr | 9 | 51 | 5.299805 | 75 | 24 | 36.29688 | null | 2.5 | 1.199951 | 1.299805 | 128 | 7.469727 | null | null | null | 1 | 3 | no(M2 and SIP pres) | 3 |
743 | 61.77399 | 1 | male | 0 | 9 | 181 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 21,076 | 12,039.4688 | null | 16 | white | 13.699219 | 16 | 0.919922 | 0.86499 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 9 | 110 | 6 | 70 | 16 | 36.59375 | null | 3.599609 | 0.699951 | 1.299805 | 141 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
744 | 55.23297 | 1 | female | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 9 | 233,772 | 97,798.75 | null | 39.666657 | other | 27.5 | 34 | 0.763916 | 0.688965 | 1 | 1 | 0 | no | null | null | no dnr | 19 | 60 | 11.298828 | 115 | 8 | 36.39844 | 230 | 2.799805 | 0.799927 | 1.399902 | 125 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 2.753906 |
745 | 72.42694 | 1 | female | 1 | 9 | 9 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 26 | 69,587 | 34,518 | null | 37.5 | other | 29.097656 | 47 | 0.326965 | 0.142975 | 2 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 8 | 103 | 8.398438 | 135 | 32 | 37.69531 | 172.5 | 3.099609 | 4.699219 | 1.299805 | 153 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 3.146973 |
746 | 80.38599 | 1 | male | 0 | 5 | 215 | Colon Cancer | Cancer | 2 | 8 | $25-$50k | 0 | 11,109 | 6,680.4805 | null | 9 | white | 15.398438 | 25 | 0.810913 | 0.594971 | 1 | 1 | 0 | metastatic | 0.9 | 0.3 | no dnr | 5 | 73 | 5.599609 | 72 | 18 | 36.19531 | null | null | null | 1.099854 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
747 | 74.12695 | 1 | male | 1 | 3 | 3 | Coma | Coma | 1 | 14 | under $11k | 100 | 22,541 | 11,522.2422 | null | 24 | white | 22.398438 | 13 | 0.166992 | 0.112 | 1 | 0 | 1 | no | null | null | dnr after sadm | 3 | 82 | 9.699219 | 50 | 14 | 35 | 430 | 4.099609 | null | 0.899902 | 134 | 7.479492 | null | null | null | null | null | <2 mo. follow-up | 4.672852 |
748 | 34.32199 | 1 | female | 0 | 40 | 150 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 10 | $11-$25k | 55 | 271,769 | 136,256.625 | null | 26.5 | hispanic | 28.597656 | 39 | 0.638916 | 0.537964 | 4 | 1 | 0 | no | 0.8 | 0.6 | no dnr | 40 | 115 | 13.199219 | 110 | 16 | 39.5 | 166.65625 | null | 0.699951 | 7.399414 | 136 | 7.359375 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
749 | 51.491 | 1 | female | 1 | 90 | 90 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | $11-$25k | 37 | 1,056,280 | 463,356.75 | null | 38 | white | 36 | 59 | 0.395996 | 0.276978 | 6 | 0 | 0 | no | null | null | dnr after sadm | 88 | 63 | 39 | 135 | 36 | 37.09375 | 220 | null | 2.699707 | 3.699707 | 129 | 7.5 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
750 | 64.92499 | 0 | female | 0 | 6 | 1,378 | CHF | COPD/CHF/Cirrhosis | 3 | 5 | null | 0 | 22,303 | 10,978.2969 | null | 23 | hispanic | 21.699219 | 29 | 0.842896 | 0.741943 | 1 | 1 | 0 | no | null | null | no dnr | 6 | 60 | 7.5 | 135 | 28 | 36.39844 | 258.3125 | null | 0.699951 | 0.799927 | 142 | 7.329102 | null | null | null | 3 | 3 | null | 3 |
751 | 71.95599 | 1 | male | 0 | 10 | 137 | CHF | COPD/CHF/Cirrhosis | 0 | null | null | 0 | 35,928 | 18,626.0938 | null | 18.5 | asian | 24.5 | 38 | 0.779907 | 0.647949 | 1 | 0 | 0 | no | 0.95 | 0.6 | no dnr | 10 | 55 | 6.199219 | 105 | 24 | 39.19531 | null | null | 1.199951 | 1.899902 | 133 | null | null | null | null | null | null | null | 2.697266 |
752 | 60.59097 | 0 | female | 0 | 12 | 1,376 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 35,397 | 18,058.4375 | null | 12.5 | white | 4.299805 | 17 | 0.93396 | 0.843994 | 1 | 0 | 0 | metastatic | 0.95 | 0.8 | no dnr | 12 | 81 | 7.5 | 120 | 22 | 38.39844 | null | 4.699219 | 0.5 | 1 | 139 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
753 | 33.09 | 1 | male | 1 | 24 | 24 | MOSF w/Malig | ARF/MOSF | 0 | null | null | 55 | 216,416 | 96,186.9375 | null | 31.666656 | asian | 37.296875 | 37 | 0.082993 | 0.031998 | 7 | 0 | 0 | yes | 0.1 | 0.001 | no dnr | 24 | 110 | 3 | 160 | 12 | 35.5 | 113.84375 | null | 0.5 | 0.5 | 135 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.698242 |
754 | 74.74896 | 1 | male | 0 | 4 | 473 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 10,758 | 4,629.7305 | null | 6 | white | 16.796875 | 38 | 0.866943 | 0.779907 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 4 | 65 | 5 | 110 | 24 | 36 | null | 5.5 | 0.799927 | 1.5 | 130 | null | null | null | null | null | null | null | 2.025391 |
755 | 50.90198 | 1 | male | 0 | 13 | 790 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | $25-$50k | 0 | 37,558 | 23,093.8125 | null | 15.5 | white | 16.398438 | 21 | 0.921997 | 0.86792 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 13 | 68 | 11 | 110 | 20 | 37.79688 | null | 4.199219 | 1.399902 | 1.299805 | 132 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
756 | 55.866 | 1 | male | 0 | 14 | 783 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | $25-$50k | 0 | 68,122 | 30,441.1719 | null | 14 | white | 20 | 40 | 0.885986 | 0.80896 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 14 | 70 | 22.597656 | 140 | 20 | 36 | null | 4.699219 | 1.099854 | 1.899902 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
757 | 77.396 | 0 | male | 0 | 6 | 1,375 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $25-$50k | 0 | 9,246 | 5,969.9688 | null | 10 | white | 13.398438 | 16 | 0.891968 | 0.81897 | 1 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 6 | 80 | 9.298828 | 80 | 20 | 37.09375 | 357.125 | null | 0.399963 | 1.299805 | 137 | 7.469727 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
758 | 63.017 | 0 | male | 0 | 14 | 1,374 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | $25-$50k | 26 | 133,878 | 63,155.6875 | null | 16.666656 | white | 20.5 | 25 | 0.759888 | 0.68396 | 5 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 14 | 57 | 6.899414 | 80 | 8 | 37.19531 | 144 | 2.599609 | 0.899902 | 0.899902 | 137 | 7.449219 | null | null | null | 0 | null | null | 0.4948 |
759 | 41.974 | 0 | male | 0 | 53 | 1,373 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 328,134 | null | null | 35.5 | white | 53.695313 | 73 | 0.21698 | 0.120987 | 1 | 0 | 0 | no | 0.4 | 0.4 | no dnr | 53 | 50 | 5.699219 | 135 | 30 | 35.09375 | 56 | 2.799805 | 5.599609 | 3.099609 | 142 | 7.40918 | null | null | null | null | null | null | 2.099609 |
760 | 67.88495 | 1 | male | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 18 | $25-$50k | 26 | 181,177 | 83,650.4375 | null | 25 | white | 24.597656 | 33 | 0.664917 | 0.567993 | 4 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 24 | 73 | 25.796875 | 110 | 22 | 36.39844 | 230 | 2.799805 | 1.799805 | 1.399902 | 131 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 2.439941 |
761 | 46.48297 | 0 | female | 0 | 16 | 1,373 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 37 | 95,454 | 46,194.7812 | null | 17.333328 | white | 22.398438 | 35 | 0.759888 | 0.68396 | 5 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 16 | 75 | 10.298828 | 130 | 48 | 38 | 427 | null | null | 0.799927 | 141 | 7.30957 | null | null | null | null | null | no(M2 and SIP pres) | 2.946777 |
762 | 64.51697 | 1 | male | 0 | 17 | 249 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 125,379 | 72,966.375 | null | 24.666656 | white | 21.597656 | 22 | 0.809937 | 0.692993 | 6 | 0 | 0 | no | null | null | no dnr | 17 | 67 | 8.398438 | 100 | 24 | 36 | null | null | null | 1.299805 | 129 | null | null | null | null | 0 | null | SIP>=30 | 0.4948 |
763 | 65.711 | 1 | female | 0 | 44 | 394 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | >$50k | 0 | 497,053 | 228,884.625 | null | 38.75 | white | 37.59375 | 60 | 0.422974 | 0.302979 | 9 | 0 | 0 | no | null | null | no dnr | 44 | 50 | 13.699219 | 95 | 12 | 38.5 | 106.65625 | 3.599609 | 2.399902 | 5 | 144 | 7.5 | null | null | null | null | 0 | null | 0 |
764 | 73.42896 | 1 | male | 0 | 14 | 413 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | >$50k | 0 | 79,641 | 39,536.7812 | null | 30 | white | 26.097656 | 33 | 0.745972 | 0.599976 | 1 | 0 | 0 | no | null | null | no dnr | 14 | 53 | 19.398438 | 80 | 20 | 36.39844 | 155.09375 | null | null | 1.399902 | 137 | 7.259766 | null | null | null | null | 1 | null | 1 |
765 | 34.05899 | 0 | female | 0 | 36 | 1,368 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | under $11k | 0 | 250,630 | 105,455.062 | null | 23.25 | black | 22.199219 | 11 | 0.895996 | 0.85791 | 2 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 36 | 103 | 21.898438 | 105 | 18 | 38.79688 | 257.5 | null | null | 0.5 | 133 | 7.469727 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
766 | 32.40198 | 1 | female | 1 | 18 | 18 | MOSF w/Malig | ARF/MOSF | 2 | 17 | $25-$50k | 44 | 262,612 | 123,059.438 | null | 33.666657 | white | 46.59375 | 69 | 0.007999 | 0.001 | 12 | 0 | 0 | yes | null | null | dnr after sadm | 8 | 107 | 13.099609 | 120 | 28 | 36.79688 | 142.5 | null | 36 | 3.899902 | 142 | 7.509766 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
767 | 28.30099 | 0 | male | 0 | 37 | 1,366 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 194,198 | 119,175.312 | null | 15.5 | white | 22.097656 | 30 | 0.924927 | 0.872925 | 1 | 0 | 0 | no | null | null | no dnr | 37 | 67 | 6.299805 | 135 | 16 | 36.29688 | null | null | null | 1.599854 | 139 | null | null | null | null | null | null | null | 2.690918 |
768 | 56.323 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 100 | 151,266 | 68,650.875 | null | 32 | white | 73.1875 | 82 | 0 | 0 | 14 | 1 | 0 | no | null | null | no dnr | 3 | 0 | 15.398438 | 135 | 10 | 38.5 | 142 | null | null | 3.199707 | 132 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.596191 |
769 | 47.98099 | 0 | female | 0 | 4 | 1,364 | Lung Cancer | Cancer | 2 | 18 | null | 0 | null | null | null | 9 | white | 16.5 | 12 | 0.754883 | 0.497986 | 1 | 0 | 0 | metastatic | null | null | null | null | 72 | 8.298828 | 100 | 20 | 37.19531 | null | null | null | 0.799927 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.524902 |
770 | 70.125 | 1 | female | 1 | 11 | 11 | Coma | Coma | 0 | null | null | 55 | 96,471 | 46,450.0938 | null | 40.5 | white | 30 | 47 | 0.210999 | 0.148987 | 1 | 0 | 0 | no | null | null | dnr after sadm | 9 | 122 | 37 | 135 | 28 | 38.5 | 113.32812 | null | null | 1.199951 | 140 | 7.539062 | null | null | null | null | null | <2 mo. follow-up | 2.359863 |
771 | 35.31799 | 1 | female | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 37 | 212,409 | 97,678.0625 | null | 35.666657 | black | 33.898438 | 36 | 0.609985 | 0.503906 | 2 | 0 | 0 | no | null | null | no dnr | 18 | 70 | 11 | 130 | 22 | 38.89844 | 37 | null | 1.199951 | 0.799927 | 134 | 7.199219 | null | null | null | null | null | <2 mo. follow-up | 2.666016 |
772 | 52.827 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 14 | >$50k | 44 | 116,166 | 56,024.5312 | null | 29.5 | white | 39.695313 | 74 | 0.232971 | 0.132996 | 7 | 0 | 0 | no | null | null | dnr after sadm | 6 | 53 | 12.398438 | 110 | 24 | 39.5 | null | null | 25.597656 | 7.799805 | 145 | null | null | null | null | null | 7 | <2 mo. follow-up | 7 |
773 | 68.64899 | 1 | male | 0 | 20 | 45 | CHF | COPD/CHF/Cirrhosis | 5 | 18 | $11-$25k | 0 | 75,142 | 37,775.2188 | null | 15.666664 | white | 35 | 50 | 0.578979 | 0.384949 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 20 | 65 | 20.796875 | 120 | 30 | 35.79688 | 253.03125 | null | 0.5 | 3.299805 | 127 | 7.429688 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
774 | 69.52795 | 0 | male | 0 | 14 | 1,361 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 17 | >$50k | 26 | 122,312 | 61,386.375 | null | 17.333328 | white | 25.898438 | 39 | 0.598999 | 0.490967 | 8 | 0 | 0 | no | null | null | no dnr | 14 | 68 | 19.398438 | 110 | 40 | 39.5 | 295 | 2.199707 | 0.399963 | 0.599976 | 131 | 7.549805 | null | null | null | null | 0 | SIP>=30 | 0 |
775 | 63.05798 | 1 | male | 0 | 71 | 1,016 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 37 | 600,192 | 274,269.75 | null | 45.5 | white | 32.695313 | 62 | 0.41095 | 0.291992 | 6 | 1 | 0 | no | null | null | no dnr | 71 | 52 | 10.699219 | 120 | 38 | 39.09375 | 198 | null | null | 2.099609 | 140 | 7.449219 | null | null | null | null | null | null | 3.199707 |
776 | 66.09198 | 1 | male | 0 | 4 | 54 | Lung Cancer | Cancer | 1 | 18 | >$50k | 0 | 8,272 | 3,430.8106 | null | 11 | asian | 17 | 11 | 0.704956 | 0.419983 | 1 | 0 | 0 | metastatic | 0.75 | 0.25 | no dnr | 4 | 83 | 6.299805 | 90 | 20 | 36.59375 | null | null | null | 0.799927 | 132 | null | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
777 | 70.48297 | 1 | female | 0 | 9 | 670 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | null | 0 | 19,065 | 10,006.6484 | null | 13.5 | white | 24.199219 | 31 | 0.78894 | 0.661987 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 9 | 53 | 6.899414 | 110 | 22 | 36.19531 | null | null | 1 | 0.899902 | 134 | null | null | null | null | null | 1 | null | 1 |
778 | 60.98599 | 1 | female | 0 | 82 | 433 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 864,424 | null | null | 32.75 | white | 19.699219 | 33 | 0.684937 | 0.591919 | 49 | 0 | 0 | yes | null | null | no dnr | 82 | 70 | 8.298828 | 115 | 26 | 38.19531 | 187.5 | 2.299805 | 0.799927 | 0.899902 | 136 | 7.5 | null | null | null | null | null | null | 2.479981 |
779 | 85.862 | 1 | female | 1 | 57 | 57 | COPD | COPD/CHF/Cirrhosis | 1 | null | $11-$25k | 0 | 329,169 | 131,754.125 | null | 30.75 | white | 33.898438 | 52 | 0.396973 | 0.199982 | 1 | 0 | 0 | no | null | null | dnr after sadm | 2 | 128 | 11.298828 | 155 | 14 | 36.19531 | 155 | 2.699707 | null | 1.799805 | 137 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 3.770508 |
780 | 59.81097 | 1 | female | 0 | 63 | 232 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 44 | 401,801 | 180,741.5 | null | 34.75 | black | 30.097656 | 47 | 0.471985 | 0.352966 | 6 | 0 | 0 | no | 0.15 | 0.1 | no dnr | 63 | 93 | 28.296875 | 140 | 30 | 38.5 | 147.5 | 1.799805 | 0.699951 | 0.799927 | 129 | 7.469727 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
781 | 56.65399 | 0 | female | 0 | 15 | 1,355 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 61,711 | 29,678.0781 | null | 24.666656 | black | 8.699219 | 20 | 0.910889 | 0.792969 | 1 | 0 | 0 | metastatic | 0.8 | 0.7 | no dnr | 15 | 80 | 6.799805 | 116 | 24 | 38.39844 | null | 3.599609 | 4.699219 | 0.899902 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.257324 |
782 | 82.086 | 0 | male | 0 | 7 | 1,354 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 22,899 | 11,851.4297 | null | 12.5 | other | 27.199219 | 46 | 0.67688 | 0.506958 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 55 | 6.799805 | 120 | 24 | 36.29688 | null | null | null | 2.099609 | 135 | null | null | null | null | null | null | no(M2 and SIP pres) | 3.915039 |
783 | 33.5 | 0 | female | 0 | 33 | 1,353 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 158,358 | 76,204.125 | null | 11.5 | hispanic | 20 | 26 | 0.912964 | 0.880981 | 2 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 33 | 117 | 15.699219 | 76 | 34 | 36.19531 | 280 | 1.599854 | 0.199982 | 0.899902 | 130 | 7.379883 | null | null | null | 5 | 0 | SIP>=30 | 0 |
784 | 72.84094 | 1 | male | 0 | 4 | 541 | Lung Cancer | Cancer | 1 | null | null | 0 | 10,314 | 5,952.375 | null | 9 | white | 18.699219 | 15 | 0.652954 | 0.347961 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 4 | 87 | 5.5 | 80 | 18 | 36 | null | null | 1.099854 | 1.099854 | 129 | null | null | null | null | null | null | null | 2.465332 |
785 | 78.43695 | 1 | female | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | null | 61 | 106,126 | 48,244.8438 | null | 45.5 | white | 29.199219 | 34 | 0.313965 | 0.200989 | 3 | 0 | 0 | no | 0.3 | 0.2 | no dnr | 12 | 67 | 11.199219 | 60 | 24 | 38.39844 | 71.26562 | null | 0.799927 | 1 | 128 | 7.329102 | null | null | null | null | null | <2 mo. follow-up | 3.557617 |
786 | 78.00995 | 1 | male | 0 | 52 | 969 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 298,193 | 133,595.625 | null | 25.75 | white | 20.296875 | 31 | 0.671997 | 0.575928 | 11 | 0 | 0 | no | null | null | no dnr | 52 | 70 | 7.799805 | 110 | 34 | 38.69531 | 267.5 | null | null | 0.899902 | 130 | 7.459961 | null | null | null | null | null | null | 2.775879 |
787 | 67.92596 | 1 | female | 0 | 11 | 1,000 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 30,406 | 15,743.8906 | null | 19 | white | 11.599609 | 24 | 0.873901 | 0.715942 | 1 | 0 | 0 | metastatic | 0.95 | 0.8 | no dnr | 11 | 108 | 28.199219 | 108 | 20 | 36.59375 | null | 3.299805 | 2.099609 | 0.699951 | 137 | null | null | null | null | null | null | null | 2.393555 |
788 | 68.55597 | 1 | male | 0 | 5 | 923 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $25-$50k | 0 | 11,855 | 6,571.6523 | null | 8 | white | 21 | 23 | 0.839966 | 0.737915 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 93 | 7.699219 | 100 | 22 | 35.89844 | 295.1875 | null | null | 1.899902 | 139 | 7.429688 | null | null | null | null | null | null | 2.421875 |
789 | 68.68195 | 1 | male | 0 | 5 | 222 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 8,686 | 4,529.3477 | null | 8 | white | 25.398438 | 29 | 0.491943 | 0.172974 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 83 | 1.599854 | 100 | 24 | 36.39844 | null | 3 | 0.599976 | 2 | 138 | null | null | null | null | null | null | null | 2.617188 |
790 | 33.01297 | 1 | female | 0 | 12 | 68 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 26 | 77,603 | 40,723.6875 | null | 23 | white | 23 | 55 | 0.845947 | 0.792969 | 2 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 12 | 133 | 10.5 | 100 | 8 | 38.19531 | 194 | null | 0.5 | 10.798828 | 146 | 7.439453 | null | null | null | null | null | null | 2.748535 |
791 | 55.96399 | 0 | male | 0 | 22 | 1,346 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 14 | $25-$50k | 0 | 193,362 | 100,574.375 | null | 20.666656 | white | 22 | 26 | 0.671997 | 0.5 | 7 | 0 | 0 | yes | 0.8 | 0.6 | no dnr | 22 | 77 | 12.898438 | 110 | 24 | 39 | null | null | 3.699707 | 0.899902 | 146 | null | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
792 | 79.45496 | 1 | female | 0 | 6 | 636 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | >$50k | 0 | 13,703 | 8,028.125 | null | 6 | white | 17.898438 | 16 | 0.841919 | 0.73999 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 80 | 6.5 | 50 | 16 | 36.29688 | null | null | null | 1.199951 | 137 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
793 | 60.37198 | 0 | male | 0 | 20 | 1,344 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 18 | $25-$50k | 37 | 234,608 | 110,586.75 | null | 33.333313 | white | 17.398438 | 40 | 0.780884 | 0.709961 | 7 | 0 | 0 | no | 0.85 | 0.85 | no dnr | 20 | 132 | 7.799805 | 110 | 10 | 38.39844 | 272.6875 | 2 | 3 | 1.199951 | 136 | 7.459961 | null | null | null | null | 0 | null | 0 |
794 | 71.65796 | 1 | female | 1 | 28 | 28 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 37 | 477,929 | 214,188.625 | null | 41.5 | white | 36.195313 | 55 | 0.197998 | 0.105988 | 33 | 0 | 0 | no | null | null | dnr after sadm | 24 | 52 | 14 | 110 | 12 | 36.89844 | 152 | null | null | 4.199219 | 143 | 7.459961 | null | null | null | null | null | <2 mo. follow-up | 2.786133 |
795 | 95.66095 | 1 | female | 0 | 5 | 661 | CHF | COPD/CHF/Cirrhosis | 1 | 10 | null | 9 | 12,435 | 6,208.4922 | null | 14 | white | 17.796875 | 31 | 0.756958 | 0.615967 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 89 | 11.599609 | 84 | 36 | 38 | 262.9375 | 3.199707 | 0.799927 | 1.099854 | 144 | 7.419922 | null | null | null | null | 4 | null | 4 |
796 | 61.88098 | 1 | male | 1 | 55 | 55 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 44 | 777,314 | 365,120.5 | null | 48.25 | white | 37.195313 | 78 | 0.197998 | 0.105988 | 38 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 31 | 60 | 19.796875 | 140 | 30 | 39 | 114 | 2.199707 | 1.199951 | 2.799805 | 131 | 7.239258 | null | null | null | null | null | <2 mo. follow-up | 3.333496 |
797 | 72.35297 | 1 | female | 1 | 3 | 3 | CHF | COPD/CHF/Cirrhosis | 1 | 13 | $11-$25k | 100 | 25,184 | 11,041.5938 | null | 39 | white | 38.398438 | 40 | 0.037994 | 0.003 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 48 | 7.299805 | 0 | 12 | 37.19531 | 388 | 3.199707 | 1.299805 | 1.399902 | 129 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 3.769531 |
798 | 57.93597 | 1 | male | 1 | 8 | 8 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 29,521 | 16,122.7266 | null | 16.5 | white | 30.398438 | 55 | 0.598999 | 0.408997 | 1 | 0 | 0 | no | 0.3 | 0.1 | dnr after sadm | 4 | 73 | 11.798828 | 108 | 20 | 36.59375 | 523.75 | 2.299805 | 11.798828 | 1.599854 | 130 | 7.429688 | null | null | null | null | null | <2 mo. follow-up | 3.885254 |
799 | 47.82498 | 1 | male | 0 | 12 | 889 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 14 | under $11k | 0 | 29,605 | 17,551.2656 | null | 12.5 | white | 15.898438 | 10 | 0.889893 | 0.815918 | 1 | 0 | 0 | no | null | null | no dnr | 12 | 84 | 2.899902 | 80 | 16 | 35.59375 | 380 | 2.799805 | 0.399963 | 0.799927 | 140 | 7.439453 | null | null | null | 0 | null | null | 0.4948 |
800 | 70.14899 | 1 | male | 0 | 5 | 684 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 12,331 | 7,431.0938 | null | 10 | white | 15.898438 | 17 | 0.886963 | 0.810913 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 73 | 7.599609 | 90 | 18 | 36 | null | null | 1.099854 | 1.099854 | 140 | null | null | null | null | null | null | null | 2.080078 |